Live feed
Filing
SC 13D
SC 13D0001213900-20-000986·CBM BioPharma, Inc.
Schedule 13D ownership disclosure
SPHERIX INC
Security class unavailable · CUSIP: 84842R502
Event date: 2019-12-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,939,058
- Percent of class
- 40.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-20-000986
- Form type
- SC 13D
- Filer
- CBM BioPharma, Inc.
- CIK
- CIK 1799654
- Filed
- Jan 14, 2020
- Reporting period
- Dec 05, 2019
- Description
- Schedule 13D beneficial ownership